AEMETIS, INC quarterly report, Q1 FY2010

Business Context and Reporting Period

Company: AE Biofuels, Inc. (formerly AE Biofuels, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2010
Business Overview: An international biofuels company focused on developing, acquiring, and operating next-generation fuel-grade ethanol and biodiesel facilities. Key operations include a 50 MGY biodiesel plant in Kakinada, India (operating at ~10% capacity), a cellulosic ethanol demonstration facility in Butte, Montana, and a recently leased 55 MGPY ethanol facility in Keyes, California.

Key Financial Metrics

Metric Q1 2010 Q1 2009
Revenue (Sales) $2,236,838 $2,503,491
Gross Profit $27,245 $185,538
Gross Margin 1.2% 7.4%
Operating Loss $(1,127,267) $(1,709,285)
Net Loss (Consolidated) $(2,011,331) $(2,528,468)
Net Loss Attributable to AE Biofuels $(1,940,511) $(2,408,763)
Cash and Cash Equivalents $332,049 $108,827
Total Debt (Current + Long Term) $16,553,425 $15,051,493
Working Capital Deficit $(19,136,033) $(17,936,876)

Material Changes vs. Prior Period

  • Revenue Decline: Sales decreased by approximately 10.6% year-over-year, driven by lower gross margins in the India segment due to rising feedstock costs (palm stearin) outpacing the government-set price of petroleum diesel.
  • Margin Compression: Gross profit dropped significantly from $185,538 to $27,245. The company recognized $44,187 in inventory write-downs to reflect lower of cost or market valuation.
  • Expense Reduction: Selling, General, and Administrative (SG&A) expenses decreased by 40.7% to $1,009,982, primarily due to reduced professional fees and lower stock-based compensation ($100,512 vs. $167,987).
  • Debt Increase: Total debt increased by approximately $1.5 million, largely due to draws on a related-party revolving line of credit and a working capital facility to fund operations.
  • Cash Position: Cash and cash equivalents increased to $332,049 from $108,827, supported by net cash provided by financing activities of $1.1 million.

Outlook, Risks, and Contingencies

  • Going Concern Warning: The filing explicitly states that substantial doubt exists regarding the company's ability to continue as a going concern. The company has a working capital deficit of over $19 million and less than one month of operating cash on hand.
  • Debt Defaults: The company is in default on its secured term loan with the State Bank of India (UBPL subsidiary) regarding principal and interest payments since June 2009. The bank has demanded full repayment of approximately $4 million. The entire loan has been classified as current.
  • Asset Impairment Risk: The biodiesel facility in India comprises ~75% of total assets. Management notes that if revenue and gross profit forecasts are not met, a material impairment charge may be required.
  • Capital Needs: The company requires significant additional capital to fund operations, complete the Keyes, CA plant retrofit, and service debt. Failure to raise capital could force asset sales or discontinuation of operations.
  • Legal Proceedings: A pending appeal regarding a $1.75 million judgment awarded to Cordillera Fund, L.P. under dissenters' rights statutes remains outstanding.

Investor Verification Checklist

  • Debt Restructuring Status: Verify the outcome of negotiations with the State Bank of India regarding the $4 million default and potential acceleration of debt.
  • Capital Raising Progress: Confirm if the company has secured the necessary equity or debt financing to cover the identified working capital deficit and fund the Keyes plant retrofit.
  • India Operations Viability: Assess the impact of the Indian state tax policy disparity on biodiesel margins and the timeline for resolution.
  • Asset Valuation: Review the assumptions used for the recoverability of the India biodiesel facility, given the low utilization rate (10%) and recent margin compression.
  • Related Party Dependence: Evaluate the sustainability of operations given the heavy reliance on financing from related parties (e.g., Laird Cagan) and the terms of these facilities.